ALLIANCEBERNSTEIN L.P. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,121,115
-58.4%
29,472
-0.5%
0.00%
-100.0%
Q2 2023$2,697,198
-63.2%
29,607
-73.4%
0.00%
-66.7%
Q1 2023$7,328,156
+27.6%
111,1000.0%0.00%0.0%
Q4 2022$5,744,981
-45.0%
111,100
-27.3%
0.00%
-40.0%
Q3 2022$10,445,000
+40.5%
152,924
-7.0%
0.01%
+66.7%
Q2 2022$7,436,000
-18.1%
164,441
-8.0%
0.00%
-25.0%
Q1 2022$9,078,000
+140.0%
178,670
+123.3%
0.00%
+300.0%
Q4 2021$3,782,000
+44.9%
80,000
+1.0%
0.00%0.0%
Q3 2021$2,610,000
-48.4%
79,200
-1.1%
0.00%
-50.0%
Q2 2021$5,062,000
+47.3%
80,1000.0%0.00%0.0%
Q1 2021$3,437,000
-25.0%
80,1000.0%0.00%0.0%
Q4 2020$4,582,000
+89.6%
80,1000.0%0.00%
+100.0%
Q3 2020$2,417,000
-9.4%
80,100
-2.0%
0.00%
-50.0%
Q2 2020$2,668,000
+32.4%
81,700
+8.6%
0.00%
+100.0%
Q1 2020$2,015,000
-10.7%
75,200
+2.0%
0.00%0.0%
Q4 2019$2,257,000
+27.2%
73,7000.0%0.00%0.0%
Q3 2019$1,775,000
-5.0%
73,7000.0%0.00%0.0%
Q2 2019$1,868,000
+99.6%
73,700
+53.5%
0.00%0.0%
Q1 2019$936,000
+47.9%
48,0000.0%0.00%
Q4 2018$633,000
-25.8%
48,0000.0%0.00%
-100.0%
Q3 2018$853,000
-62.2%
48,000
-53.1%
0.00%
-50.0%
Q2 2018$2,254,000
+22.2%
102,443
+20.5%
0.00%
+100.0%
Q4 2017$1,845,00085,0000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders